Variables | Options | Outcome | CHR with 95% CI | AHR with 95% CI | P value |
---|
Death | Other |
---|
Age | Per each year increase | 0.86 (0.75–0.99) | | |
Sex | Male | 10 | 106 | | | |
Female | 3 | 124 | 1 | | |
Residence | Rural | 9 | 125 | 1.90 (0.58–6.12) | | |
Urban | 4 | 105 | 1 | | |
Nutritional status | Underweight | 9 | 91 | 3.36 (1.03–10.9) | 3.01 (0.80–11.4) | 0.104 |
Well nourished | 4 | 139 | 1 | 1 | |
ART adherence | Good | 7 | 195 | 1 | | |
Fair | 5 | 29 | 4.73 (1.4–14.9) | | |
Poor | 1 | 6 | 4.03 (0.4–32.7) | | |
Therapeutic food | No | 2 | 63 | 2.18 (0.48–9.84 | | |
Yes | 11 | 167 | 1 | | |
Eating disorder | No | 1 | 79 | 1 | | |
Yes | 12 | 151 | 2.44 (0.88–6.6) | | |
OIs | No | 0.25 | 52 | 1 | | |
Yes | 13 | 178 | 29.8 (0.11–78) | | |
ART start | Immediately | 2 | 82 | 1 | 1 | |
Later on | 11 | 148 | 2.84 (0.63–12.82) | 4.43 (0.84–23.34) | 0.079 |
Baseline Hgb | Per each 1 g/dl increase in hgb | 0.78 (0.63–.95) | | |
Anemia | Yes | 7 | 203 | 2.38 (1.38–4.1) | 1.55 (0.49–4.84) | 0.453 |
No | 6 | 27 | 1 | 1 | |
WHO stage | WHO stage I | 1 | 179 | 1 | 1 | |
WHO stage II | 7 | 32 | 35.2 (4.3–286) | 25.1 (2.91–48.0) | 0.003* |
WHO stage III | 5 | 5 | 15.6 (1.8–34) | 20.7 (2.16–38.3) | 0.000* |
- * statistically significant at p value below 0.05 (5%)